PMID

Data

Article Title

Organization

Discovery and antiplatelet activity of a selective PI3Kß inhibitor (MIPS-9922).

Monash University

Structural Basis for the Selective Binding of Inhibitors to 6-Hydroxymethyl-7,8-dihydropterin Pyrophosphokinase from Staphylococcus aureus and Escherichia coli.

Monash University

A potent cyclic peptide targeting SPSB2 protein as a potential anti-infective agent.

Monash University

Structure-based design and development of functionalized Mercaptoguanine derivatives as inhibitors of the folate biosynthesis pathway enzyme 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Staphylococcus aureus.

Monash University

Structure-activity relationships of privileged structures lead to the discovery of novel biased ligands at the dopamine D2 receptor.

Monash University

Synthesis and preliminary screening of novel indole-3-methanamines as 5-HT4 receptor ligands.

Monash University

Synthesis and pharmacological evaluation of dual acting antioxidant A(2A) adenosine receptor agonists.

Monash University

Inhibition of 3(17)alpha-hydroxysteroid dehydrogenase (AKR1C21) by aldose reductase inhibitors.

Monash University

Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis.

Monash University

Lactam-stabilized helical analogues of the analgesicµ-conotoxin KIIIA.

Monash University

2-Phenyl and 2-heterocyclic-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridines as inhibitors of TGF-ß1 and activin A signalling.

Monash University

Benzopyrazine derivatives: A novel class of growth factor receptor bound protein 7 antagonists.

Monash University

Synthesis and evaluation of new N6-substituted adenosine-5'-N-methylcarboxamides as A3 adenosine receptor agonists.

Monash University

Probing the fibrate binding specificity of rat liver fatty acid binding protein.

Monash University

2-aminothienopyridazines as novel adenosine A1 receptor allosteric modulators and antagonists.

Monash University

Inhibition of N-type calcium channels by phenoxyaniline and sulfonamide analogues.

Monash University

Development of [

Monash University

Examining the Role of the Linker in Bitopic

Monash University

Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A

Monash University

Development of Covalent, Clickable Probes for Adenosine A

Monash University

PDE2 inhibition by the PI3 kinase inhibitor LY294002 and analogues.

Monash University

Alkyne-Bridged α-Conotoxin Vc1.1 Potently Reverses Mechanical Allodynia in Neuropathic Pain Models.

Monash University

Novel Irreversible Agonists Acting at the A

Monash University

Development of single and mixed isoform selectivity PI3Kδ inhibitors by targeting Asn836 of PI3Kδ.

Monash University

Design, Synthesis, and Characterization of Cyclic Peptidomimetics of the Inducible Nitric Oxide Synthase Binding Epitope That Disrupt the Protein-Protein Interaction Involving SPRY Domain-Containing Suppressor of Cytokine Signaling Box Protein (SPSB) 2 and Inducible Nitric Oxide Synthase.

Monash University

Novel Human Aminopeptidase N Inhibitors: Discovery and Optimization of Subsite Binding Interactions.

Monash University

Development of Benzenesulfonamide Derivatives as Potent Glutathione Transferase Omega-1 Inhibitors.

Monash University

Hydroxamic Acid Inhibitors Provide Cross-Species Inhibition of Plasmodium M1 and M17 Aminopeptidases.

Monash University

Substituted Pyridazin-3(2 H)-ones as Highly Potent and Biased Formyl Peptide Receptor Agonists.

Monash University

Two-pronged attack: dual inhibition of Plasmodium falciparum M1 and M17 metalloaminopeptidases by a novel series of hydroxamic acid-based inhibitors.

Monash University

Probing structural requirements of positive allosteric modulators of the M4 muscarinic receptor.

Monash University

Synthesis and pharmacological profiling of analogues of benzyl quinolone carboxylic acid (BQCA) as allosteric modulators of the M1 muscarinic receptor.

Monash University

A novel series of 2,5-substituted tryptamine derivatives as vascular 5HT1B/1D receptor antagonists.

Monash University

Reviewing Hit Discovery Literature for Difficult Targets: Glutathione Transferase Omega-1 as an Example.

Monash University

A Structure-Activity Relationship Study of Bitopic N

Monash University

Discovery, Development, and Cellular Delivery of Potent and Selective Bicyclic Peptide Inhibitors of Grb7 Cancer Target.

Monash University

Benzenesulfonamide compounds and their use as therapeutic agents

Xenon Pharmaceuticals

Trk-inhibiting compound

Ono Pharmaceutical

Substituted 2-azabicycles and their use as orexin receptor modulators

Janssen Pharmaceutica

Substituted thiazole or oxazole P2X7 receptor antagonists

Axxam

Synthesis and tyrosinase inhibitory activity of novel N-hydroxybenzyl-N-nitrosohydroxylamines.

Keio University

Synthesis and biological evaluation of novel EG5 inhibitors.

University of Leipzig